Evidence map›Paper›PMID 28718839›Full record

ArticleNutrients2017

Dose-Dependent Prebiotic Effect of Lactulose in a Computer-Controlled In Vitro Model of the Human Large Intestine.

Melanie K Bothe, Annet J H Maathuis, Susann Bellmann, Jos M B M van der Vossen, Dirk Berressem, Annalena Koehler, Susann Schwejda-Guettes, Barbara Gaigg, Angelika Kuchinka-Koch, John F Stover

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Nutrients, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06995586 (The Synergistic Action of Vitamins and Dietary Supplements in Patients With Coronary Artery Bypass Grafting for Improving the Quality of Healthcare Delivery.), which is not on this map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06995586 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

The Synergistic Action of Vitamins and Dietary Supplements in Patients With Coronary Artery Bypass Grafting for Improving the Quality of Healthcare Delivery.

TypeinterventionalSponsorNicosia General HospitalRan2026 to 2028Enrolled108ConditionsCardio-pulmonary Bypass, Cardiovascular Diseases, Omega-3 Polyunsaturated Fatty Acids, Omega-3 SupplementationArmsVitamin C, Omega 3 PUFA (EPO/DHA), Lignin, Lactulose
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 62 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Development of an infant colon simulatingMicrobiology spectrum · 2024
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Microbiota reprogramming for treatment of alcohol-related liver disease.Translational research : the journal of laboratory and clinical medicine · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Melanie K BotheFresenius Kabi Deutschland GmbH, Else-Kroener-Strasse 1, 61352 Bad Homburg, Germany. melanie.bothe@fresenius-kabi.com.
Annet J H MaathuisTriskelion B.V., A TNO Company, P.O. Box 844, 3700 AV Zeist, The Netherlands. annet.maathuis@triskelion.nl.
Susann BellmannTriskelion B.V., A TNO Company, P.O. Box 844, 3700 AV Zeist, The Netherlands. susann.bellmann@triskelion.nl.
Jos M B M van der VossenThe Netherlands Organisation for Applied Scientific Research (TNO), Microbiology and Systems Biology Department, P.O. Box 360, 3700 AJ Zeist, The Netherlands. jos.vandervossen@tno.nl.
Dirk BerressemFresenius Kabi Deutschland GmbH, Borkenberg 14, 61440 Oberursel, Germany. dirk.berressem@fresenius-kabi.com.
Annalena KoehlerFresenius Kabi Deutschland GmbH, Borkenberg 14, 61440 Oberursel, Germany. annalena.koehler@fresenius-kabi.com.
Susann Schwejda-GuettesFresenius Kabi Deutschland GmbH, Borkenberg 14, 61440 Oberursel, Germany. susann.schwejda-guettes@fresenius-kabi.com.
Barbara GaiggFresenius Kabi Austria GmbH, Estermannstrasse 17, 4020 Linz, Austria. barbara.gaigg@fresenius-kabi.com.
Angelika Kuchinka-KochFresenius Kabi Austria GmbH, Estermannstrasse 17, 4020 Linz, Austria. angelika.kuchinka-koch@fresenius-kabi.com.
John F StoverFresenius Kabi Deutschland GmbH, Borkenberg 14, 61440 Oberursel, Germany. john.stover@fresenius-kabi.com.
Fresenius (Germany) · DENetherlands Organisation for Applied Scientific Research · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lactulose, a disaccharide of galactose and fructose, used as a laxative or ammonia-lowering drug and as a functional food ingredient, enhances growth of

Indexed as

Models, BiologicalAcetatesAdultAmmoniaBifidobacteriumBody Mass IndexButyratesComputer SimulationDNA, BacterialDose-Response Relationship, DrugFatty Acids, VolatileFemaleGastrointestinal MicrobiomeHumansHydrogen-Ion ConcentrationIntestine, LargeAcetatesAmmoniaButyratesDNA, BacterialFatty Acids, VolatileLactic AcidLactulosePrebioticsRNA, Ribosomal, 16SammoniaAnaerostipesBifidobacteriabutyratelactobacilliLactulosemicrobial fermentation

Identifiers

PMID28718839
PMCPMC5537881
OpenAlexW2736356701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.